A pioneer research published in 2006 compared the levels of serum concentrations of transforming growth factor-beta1 (TGF-β1) a marker of fibrosis, and ferritin between NAFL, and NASH patients [40]. The gene discussed is TGFB1; the disease is non-alcoholic fatty liver.